Print

Arch Therapeutics Licenses Groundbreaking Intellectual Property on Hemostasis  
4/28/2008 8:30:42 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Arch Therapeutics, a life science company developing and commercializing compositions that promptly stop or control bleeding, today announced it has finalized a license agreement with the Massachusetts Institute of Technology.
//-->